Both overexpression and overactive mutations of FLT3 have been implicated in different diseases, prominently in acute myeloid leukemia (AML), of which one-third of patients carry FLT3 mutants that correlated with poor prognosis [114]. Here, FLT3 is linked to acute myeloid leukemia.